BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 27861524)

  • 1. Factors Associated with Worse Lung Function in Cystic Fibrosis Patients with Persistent Staphylococcus aureus.
    Junge S; Görlich D; den Reijer M; Wiedemann B; Tümmler B; Ellemunter H; Dübbers A; Küster P; Ballmann M; Koerner-Rettberg C; Große-Onnebrink J; Heuer E; Sextro W; Mainz JG; Hammermann J; Riethmüller J; Graepler-Mainka U; Staab D; Wollschläger B; Szczepanski R; Schuster A; Tegtmeyer FK; Sutharsan S; Wald A; Nofer JR; van Wamel W; Becker K; Peters G; Kahl BC
    PLoS One; 2016; 11(11):e0166220. PubMed ID: 27861524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A systematic review of the clinical impact of small colony variants in patients with cystic fibrosis.
    Ryan H; Ballard E; Stockwell RE; Duplancic C; Thomson RM; Smith K; Bell SC
    BMC Pulm Med; 2023 Sep; 23(1):323. PubMed ID: 37658311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small Colonies, Bigger Problems? New Evidence That Staphylococcus aureus Small Colony Variants Can Worsen Lung Inflammation in Cystic Fibrosis Rats.
    Fischer AJ
    Infect Immun; 2022 Nov; 90(11):e0041322. PubMed ID: 36286497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective multicenter randomized patient recruitment and sample collection to enable future measurements of sputum biomarkers of inflammation in an observational study of cystic fibrosis.
    Liou TG; Adler FR; Argel N; Asfour F; Brown PS; Chatfield BA; Daines CL; Durham D; Francis JA; Glover B; Heynekamp T; Hoidal JR; Jensen JL; Keogh R; Kopecky CM; Lechtzin N; Li Y; Lysinger J; Molina O; Nakamura C; Packer KA; Poch KR; Quittner AL; Radford P; Redway AJ; Sagel SD; Sprandel S; Taylor-Cousar JL; Vroom JB; Yoshikawa R; Clancy JP; Elborn JS; Olivier KN; Cox DR
    BMC Med Res Methodol; 2019 Apr; 19(1):88. PubMed ID: 31027503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The
    Sadowska B; Wójcik U; Krzyżanowska-Kowalczyk J; Kowalczyk M; Stochmal A; Rywaniak J; Burzyńska J; Różalska B
    Molecules; 2019 Mar; 24(6):. PubMed ID: 30909529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of Staphylococcus aureus in cystic fibrosis pathogenesis and clinico-microbiological interactions.
    Sheykhsaran E; Abbasi A; Memar MY; Ghotaslou R; Baghi HB; Mazraeh FN; Laghousi D; Sadeghi J
    Diagn Microbiol Infect Dis; 2024 Jul; 109(3):116294. PubMed ID: 38678689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The airway microbiome of persons with cystic fibrosis correlates with acquisition and microbiological outcomes of incident
    Bowron LA; Acosta N; Thornton CS; Carpentero J; Waddell BM; Bharadwaj L; Ebbert K; Castañeda-Mogollón D; Conly JM; Rabin HR; Surette MG; Parkins MD
    Front Microbiol; 2024; 15():1353145. PubMed ID: 38690371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurement of parasternal intercostal electromyogram during an infective exacerbation in patients with cystic fibrosis.
    Reilly CC; Jolley CJ; Elston C; Moxham J; Rafferty GF
    Eur Respir J; 2012 Oct; 40(4):977-81. PubMed ID: 22267769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transposon sequencing identifies genes impacting
    Lo H-Y; Long DR; Holmes EA; Penewit K; Hodgson T; Lewis JD; Waalkes A; Salipante SJ
    Infect Immun; 2023 Oct; 91(10):e0022823. PubMed ID: 37676013
    [No Abstract]   [Full Text] [Related]  

  • 10. Upper Airway Findings and Markers of Lung Disease Progression in Patients with Cystic Fibrosis.
    Steffen LM; Pezzin LS; Sulis N; Steffen N; Pinto LA
    Int Arch Otorhinolaryngol; 2020 Oct; 24(4):e434-e437. PubMed ID: 33101507
    [No Abstract]   [Full Text] [Related]  

  • 11. Cystic fibrosis lung environment and Pseudomonas aeruginosa infection.
    Bhagirath AY; Li Y; Somayajula D; Dadashi M; Badr S; Duan K
    BMC Pulm Med; 2016 Dec; 16(1):174. PubMed ID: 27919253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New horizons for cystic fibrosis treatment.
    Fajac I; De Boeck K
    Pharmacol Ther; 2017 Feb; 170():205-211. PubMed ID: 27916649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complementary and alternative medicine use in children with cystic fibrosis.
    Giangioppo S; Kalaci O; Radhakrishnan A; Fleischer E; Itterman J; Lyttle B; Price A; Radhakrishnan D
    Complement Ther Clin Pract; 2016 Nov; 25():68-74. PubMed ID: 27863612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe disease in Cystic Fibrosis and fecal calprotectin levels.
    Parisi GF; Papale M; Rotolo N; Aloisio D; Tardino L; Scuderi MG; Di Benedetto V; Nenna R; Midulla F; Leonardi S
    Immunobiology; 2017 Mar; 222(3):582-586. PubMed ID: 28012584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lumacaftor/Ivacaftor Treatment of Patients with Cystic Fibrosis Heterozygous for F508del-CFTR.
    Rowe SM; McColley SA; Rietschel E; Li X; Bell SC; Konstan MW; Marigowda G; Waltz D; Boyle MP;
    Ann Am Thorac Soc; 2017 Feb; 14(2):213-219. PubMed ID: 27898234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pancreatic enzyme replacement therapy for people with cystic fibrosis.
    Somaraju UR; Solis-Moya A
    Cochrane Database Syst Rev; 2016 Nov; 11(11):CD008227. PubMed ID: 27878805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long term azithromycin therapy in patients with cystic fibrosis.
    Emiralioğlu N; Öztürk Z; Yalçın E; Doğru D; Özçelik U; Kiper N
    Turk J Pediatr; 2016; 58(1):34-40. PubMed ID: 27922234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physiological markers of exercise capacity and lung disease severity in cystic fibrosis.
    Smith L; Reilly CC; MacBean V; Jolley CJ; Elston C; Moxham J; Rafferty GF
    Respirology; 2017 May; 22(4):714-720. PubMed ID: 27882640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comorbidities and the risk of mortality in patients with bronchiectasis: an international multicentre cohort study.
    McDonnell MJ; Aliberti S; Goeminne PC; Restrepo MI; Finch S; Pesci A; Dupont LJ; Fardon TC; Wilson R; Loebinger MR; Skrbic D; Obradovic D; De Soyza A; Ward C; Laffey JG; Rutherford RM; Chalmers JD
    Lancet Respir Med; 2016 Dec; 4(12):969-979. PubMed ID: 27864036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Staphylococcus aureus Leukocidin LukED and HIV-1 gp120 Target Different Sequence Determinants on CCR5.
    Tam K; Schultz M; Reyes-Robles T; Vanwalscappel B; Horton J; Alonzo F; Wu B; Landau NR; Torres VJ
    mBio; 2016 Dec; 7(6):. PubMed ID: 27965453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.